Nexalin Technology (NXL) Competitors $4.22 +0.12 (+2.93%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends NXL vs. TLSI, KRMD, GUTS, SRTS, EDAP, FONR, ECOR, LNSR, MGRM, and TELAShould you be buying Nexalin Technology stock or one of its competitors? The main competitors of Nexalin Technology include TriSalus Life Sciences (TLSI), KORU Medical Systems (KRMD), Fractyl Health (GUTS), Sensus Healthcare (SRTS), Edap Tms (EDAP), FONAR (FONR), electroCore (ECOR), LENSAR (LNSR), Monogram Orthopaedics (MGRM), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry. Nexalin Technology vs. TriSalus Life Sciences KORU Medical Systems Fractyl Health Sensus Healthcare Edap Tms FONAR electroCore LENSAR Monogram Orthopaedics TELA Bio TriSalus Life Sciences (NASDAQ:TLSI) and Nexalin Technology (NASDAQ:NXL) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, community ranking, media sentiment, dividends and profitability. Does the MarketBeat Community believe in TLSI or NXL? TriSalus Life Sciences received 9 more outperform votes than Nexalin Technology when rated by MarketBeat users. CompanyUnderperformOutperformTriSalus Life SciencesOutperform Votes10100.00% Underperform VotesNo VotesNexalin TechnologyOutperform Votes1100.00% Underperform VotesNo Votes Do analysts prefer TLSI or NXL? TriSalus Life Sciences presently has a consensus price target of $12.08, indicating a potential upside of 207.46%. Nexalin Technology has a consensus price target of $3.00, indicating a potential downside of 28.91%. Given TriSalus Life Sciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe TriSalus Life Sciences is more favorable than Nexalin Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 2 Strong Buy rating(s) 3.25Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, TLSI or NXL? TriSalus Life Sciences has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.5, indicating that its stock price is 250% more volatile than the S&P 500. Do institutionals & insiders have more ownership in TLSI or NXL? 2.6% of TriSalus Life Sciences shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 32.8% of TriSalus Life Sciences shares are owned by company insiders. Comparatively, 24.0% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is TLSI or NXL more profitable? TriSalus Life Sciences has a net margin of -206.24% compared to Nexalin Technology's net margin of -3,407.98%. TriSalus Life Sciences' return on equity of 0.00% beat Nexalin Technology's return on equity.Company Net Margins Return on Equity Return on Assets TriSalus Life Sciences-206.24% N/A -241.80% Nexalin Technology -3,407.98%-187.59%-167.21% Which has stronger valuation and earnings, TLSI or NXL? Nexalin Technology has lower revenue, but higher earnings than TriSalus Life Sciences. Nexalin Technology is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTriSalus Life Sciences$18.51M6.47-$59.04M-$2.49-1.58Nexalin Technology$110K493.36-$4.65M-$0.64-6.59 Does the media favor TLSI or NXL? In the previous week, TriSalus Life Sciences had 18 more articles in the media than Nexalin Technology. MarketBeat recorded 23 mentions for TriSalus Life Sciences and 5 mentions for Nexalin Technology. TriSalus Life Sciences' average media sentiment score of 0.61 beat Nexalin Technology's score of 0.24 indicating that TriSalus Life Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TriSalus Life Sciences 3 Very Positive mention(s) 3 Positive mention(s) 8 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Nexalin Technology 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryTriSalus Life Sciences beats Nexalin Technology on 13 of the 18 factors compared between the two stocks. Ad Traders Agency5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here.Click here to pay just $5 for a full year of Stealth Trades Get Nexalin Technology News Delivered to You Automatically Sign up to receive the latest news and ratings for NXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXL vs. The Competition Export to ExcelMetricNexalin TechnologyElectromedical equipment IndustryBusiness SectorNASDAQ ExchangeMarket Cap$54.28M$3.61B$7.23B$8.74BDividend YieldN/A1.65%2.38%4.08%P/E Ratio-6.5911.4619.5113.55Price / Sales493.3699.25166.8787.67Price / CashN/A46.1728.3835.24Price / Book10.823.804.805.93Net Income-$4.65M$92.21M$120.67M$225.73M7 Day Performance11.05%-2.39%10.42%-1.34%1 Month Performance219.70%13.84%12.48%1.15%1 Year Performance1,288.16%26.34%35.40%24.02% Nexalin Technology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXLNexalin Technology1.0829 of 5 stars$4.22+2.9%$3.00-28.9%+1,283.6%$54.28M$110,000.00-6.593Earnings ReportShort Interest ↑TLSITriSalus Life Sciences4.3354 of 5 stars$4.35+2.8%N/A-0.5%$132.63M$18.51M-1.74106Analyst ForecastAnalyst RevisionNews CoverageGap UpKRMDKORU Medical Systems3.0117 of 5 stars$2.86-0.3%N/A+44.1%$131.13M$28.52M-11.4480Analyst ForecastNews CoverageGUTSFractyl Health1.6962 of 5 stars$2.46-0.4%N/AN/A$117.91M$120,000.000.00102Earnings ReportInsider SellingNews CoverageSRTSSensus Healthcare4.1171 of 5 stars$6.93+2.4%N/A+263.8%$113.58M$24.41M16.9040Analyst ForecastAnalyst RevisionNews CoverageEDAPEdap Tms3.0541 of 5 stars$2.70+5.1%N/A-47.9%$100.17M$65.42M-4.15307FONRFONAR2.3415 of 5 stars$14.88-1.0%N/A-10.7%$94.19M$102.88M9.73480Analyst DowngradeShort Interest ↓News CoverageECORelectroCore0.8757 of 5 stars$13.30-1.4%N/A+80.2%$85.79M$16.03M-6.0550Short Interest ↑Analyst RevisionNews CoverageHigh Trading VolumeLNSRLENSAR3.1336 of 5 stars$7.33-0.7%N/A+237.1%$85.09M$45.12M-5.02110Short Interest ↓Positive NewsGap DownMGRMMonogram Orthopaedics0.965 of 5 stars$2.24+1.4%N/A-26.0%$77.71M$370,000.00-6.5928Upcoming EarningsNews CoverageGap DownTELATELA Bio4.0211 of 5 stars$2.98-3.2%N/A-38.5%$73.65M$64.74M-1.76120Short Interest ↓ Related Companies and Tools Related Companies TriSalus Life Sciences Alternatives KORU Medical Systems Alternatives Fractyl Health Alternatives Sensus Healthcare Alternatives Edap Tms Alternatives FONAR Alternatives electroCore Alternatives LENSAR Alternatives Monogram Orthopaedics Alternatives TELA Bio Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NXL) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nexalin Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nexalin Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
